tradingkey.logo
tradingkey.logo
Search

Lexaria Bioscience Corp

LEXX
Add to Watchlist
0.391USD
-0.005-1.34%
Close 07-31 16:00ETQuotes delayed by 15 min
9.69MMarket Cap
LossP/E TTM

LEXX Financials

See Lexaria Bioscience Corp's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Lexaria Bioscience Corp Earnings Date

Latest Release
Jul 13, 2026
EPS / Forecast
-0.08/-0.09
Revenue / Forecast
0.00/50.00K
Period
FY2025 Earnings
Revenue(YoY)
705.92K
52.05%
EPS(YoY)
-0.66
-41.30%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
61.24%-0.08
61.71%-0.06
54.00%-0.07
0.97%-0.14
-61.03%-0.21
-156.78%-0.15
-24.49%-0.16
---0.14
65.08%-0.13
72.34%-0.06
55.84%-0.13
----
---0.37
---0.22
---0.30
---1.24
----
----
----
----
----
Revenue
-100.00%0.00
-88.51%20.00K
-100.00%0.00
107.14%174.00K
107.14%174.00K
20.00%174.00K
21.58%183.92K
--84.00K
8.10%84.00K
624.09%145.00K
54.78%151.28K
----
-22.07%77.71K
-34.67%20.02K
604.14%97.73K
258.31%111.15K
-51.13%99.72K
-84.04%30.65K
-95.31%13.88K
-51.52%31.02K
460.24%204.06K
Net Profit
47.45%-1.99M
46.56%-1.45M
41.01%-1.60M
-23.39%-2.70M
-112.67%-3.79M
-317.71%-2.71M
-129.26%-2.70M
---2.18M
24.87%-1.78M
49.96%-649.54K
32.84%-1.18M
----
0.48%-2.37M
8.95%-1.30M
11.90%-1.76M
-24.56%-1.47M
6.81%-2.38M
-452.82%-1.43M
-186.36%-1.99M
-42.69%-1.18M
-87.82%-2.56M
Net Margin
----
-365.18%-7263.66%
----
40.45%-1550.13%
-2.56%-2178.51%
-246.87%-1561.48%
-87.86%-1471.61%
---2603.06%
30.75%-2124.18%
93.12%-450.16%
56.73%-783.35%
----
---3067.38%
---6545.01%
---1810.31%
---2891.05%
----
----
----
----
----
Gross Margin
----
0.00%100.00%
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
1.76%98.52%
--100.00%
19.62%100.00%
17.33%100.00%
15.47%96.81%
----
--83.60%
--85.23%
--83.84%
--71.87%
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00%
----
----
----
----
----
Revenue
-100.00%0.00
-88.51%20.00K
-100.00%0.00
107.14%174.00K
107.14%174.00K
20.00%174.00K
21.58%183.92K
--84.00K
8.10%84.00K
624.09%145.00K
54.78%151.28K
----
-22.07%77.71K
-34.67%20.02K
604.14%97.73K
258.31%111.15K
-51.13%99.72K
-84.04%30.65K
-95.31%13.88K
-51.52%31.02K
460.24%204.06K
Operating profit
46.84%-1.99M
47.22%-1.45M
41.52%-1.57M
-22.04%-2.69M
-115.18%-3.75M
-311.83%-2.75M
-136.20%-2.69M
---2.20M
27.40%-1.74M
49.53%-668.00K
32.81%-1.14M
----
0.72%-2.40M
8.63%-1.32M
15.38%-1.70M
-23.50%-1.51M
3.14%-2.42M
-36.35%-1.45M
-172.30%-2.00M
-38.85%-1.22M
-77.89%-2.50M
Net Profit
47.45%-1.99M
46.56%-1.45M
41.01%-1.60M
-23.39%-2.70M
-112.67%-3.79M
-317.71%-2.71M
-129.26%-2.70M
---2.18M
24.87%-1.78M
49.96%-649.54K
32.84%-1.18M
----
0.48%-2.37M
8.95%-1.30M
11.90%-1.76M
-24.56%-1.47M
6.81%-2.38M
-452.82%-1.43M
-186.36%-1.99M
-42.69%-1.18M
-87.82%-2.56M
Current assets
-30.00%4.06M
-25.30%5.77M
-39.23%5.36M
-56.09%3.47M
-36.14%5.81M
42.60%7.72M
227.65%8.83M
259.04%7.90M
114.69%9.09M
35.30%5.42M
-49.74%2.69M
-68.47%2.20M
-48.92%4.24M
-62.13%4.00M
-50.84%5.36M
-43.92%6.98M
-14.39%8.29M
-3.42%10.57M
733.62%10.90M
545.98%12.44M
----
Total current liabilities
-74.24%383.41K
-88.22%214.67K
389.10%1.46M
35.84%1.49M
853.64%1.49M
2130.16%1.82M
139.15%297.80K
310.64%1.10M
-85.22%156.05K
-63.38%81.72K
-55.77%124.52K
37.98%267.74K
410.53%1.06M
34.79%223.13K
18.44%281.52K
26.59%194.04K
-6.51%206.83K
-58.55%165.54K
-1.97%237.70K
-32.23%153.28K
----
Total assets
-29.07%4.78M
-25.24%6.49M
-38.22%6.05M
-52.92%4.18M
-32.71%6.74M
36.61%8.68M
170.04%9.79M
187.54%8.87M
91.20%10.02M
30.84%6.35M
-41.63%3.63M
-60.63%3.08M
-42.66%5.24M
-57.47%4.85M
-47.10%6.21M
-40.95%7.83M
-13.36%9.14M
-6.23%11.41M
440.21%11.75M
369.04%13.27M
----
Total liabilities
-72.25%437.09K
-85.55%277.00K
282.11%1.53M
30.08%1.57M
480.32%1.57M
838.67%1.92M
57.34%399.72K
199.26%1.21M
-77.36%271.38K
-8.48%204.20K
-9.76%254.04K
100.51%403.91K
432.27%1.20M
14.65%223.13K
1.51%281.52K
-0.90%201.44K
-19.98%225.16K
-58.55%194.62K
-21.50%277.33K
-41.29%203.26K
----
Total equity
-15.92%4.34M
-8.14%6.21M
-51.85%4.52M
-66.02%2.60M
-46.99%5.17M
9.97%6.76M
178.53%9.39M
185.78%7.66M
141.20%9.75M
32.73%6.15M
-43.14%3.37M
-64.89%2.68M
-54.66%4.04M
-58.72%4.63M
-48.28%5.93M
-41.57%7.63M
-13.18%8.91M
-4.13%11.22M
529.79%11.47M
426.28%13.06M
----
Net operating income
54.38%-1.64M
-44.46%-2.16M
63.90%-984.10K
-39.69%-2.64M
-183.08%-3.58M
-141.75%-1.50M
-130.70%-2.73M
-16.65%-1.89M
29.11%-1.27M
50.01%-619.61K
5.11%-1.18M
-37.83%-1.62M
-41.84%-1.79M
2.96%-1.24M
-6.77%-1.25M
-9.02%-1.18M
-7.83%-1.26M
-40.17%-1.28M
-44.07%-1.17M
-68.80%-1.08M
----
Net investment
-39.33%-27.09K
-93.26%-53.91K
86.51%-5.10K
-126.88%-157.88K
11.63%-19.44K
51.05%-27.89K
5.55%-37.80K
-1.68%-69.59K
34.61%-22.00K
-74.37%-56.99K
-14.88%-40.03K
-36.75%-68.44K
11.35%-33.65K
5.05%-32.68K
40.15%-34.84K
-2502150.00%-50.05K
46.33%-37.96K
-112.73%-34.42K
-908.05%-58.22K
99.99%-2.00
----
Net financing
-100.00%0.00
25873.16%3.04M
-20.05%3.47M
--0.00
-66.51%1.69M
-99.66%11.72K
138.84%4.35M
100.00%0.00
194.67%5.04M
30717.89%3.45M
--1.82M
-986.01%-121.69K
15375.06%1.71M
200.00%11.20K
100.00%0.00
-100.28%-11.21K
---11.20K
-100.12%-11.20K
-25.32%-10.99K
4554.72%3.97M
----

FAQs

What is the total revenue of Lexaria Bioscience Corp?

According to Lexaria Bioscience Corp's FY2025 earnings report, its total revenue reached 705.92K, with a year-on-year change of 464.28K.

What are the current assets of Lexaria Bioscience Corp?

According to Lexaria Bioscience Corp's FY2025 earnings report, its current assets were 3.47M, with a year-on-year change of -56.09.

What are the total assets of Lexaria Bioscience Corp?

According to Lexaria Bioscience Corp's FY2025 earnings report, its total assets of Lexaria Bioscience Corp were 4.18M, with a year-on-year change of -52.92.

What are the total liabilities of Lexaria Bioscience Corp?

According to Lexaria Bioscience Corp's FY2025 earnings report, its total liabilities of Lexaria Bioscience Corp were 1.57M, with a year-on-year change of 30.08.

What is the total equity of Lexaria Bioscience Corp?

According to Lexaria Bioscience Corp's FY2025 earnings report, its total equity of Lexaria Bioscience Corp was 2.60M, with a year-on-year change of -66.02.

What is the net operating income of Lexaria Bioscience Corp?

According to Lexaria Bioscience Corp's FY2025 earnings report, its net operating income of Lexaria Bioscience Corp was -11.88M, with a year-on-year change of -106.51.

What is the net investment of Lexaria Bioscience Corp?

According to Lexaria Bioscience Corp's FY2025 earnings report, its net investment of Lexaria Bioscience Corp was -243.02K, with a year-on-year change of -28.85.

What is the net financing of Lexaria Bioscience Corp?

According to Lexaria Bioscience Corp's FY2025 earnings report, its net financing of Lexaria Bioscience Corp was 6.05M, with a year-on-year change of -41.39.

What is the Earnings Per Share (EPS) of Lexaria Bioscience Corp?

According to Lexaria Bioscience Corp's FY2025 earnings report, its Earnings Per Share (EPS) was -0.66, with a year-on-year change of -41.30.

What is the net income of Lexaria Bioscience Corp?

According to Lexaria Bioscience Corp's FY2025 earnings report, its net income was -11.90M, with a year-on-year change of -105.37.

What is the net margin of Lexaria Bioscience Corp?

According to Lexaria Bioscience Corp's FY2025 earnings report, its net profit margin was -1687.36, with a year-on-year change of -34.87.

What is the gross margin of Lexaria Bioscience Corp?

According to Lexaria Bioscience Corp's FY2025 earnings report, its gross margin was 99.61, with a year-on-year change of 0.66.

What is the Return on Equity (ROE) of Lexaria Bioscience Corp?

According to Lexaria Bioscience Corp's FY2025 earnings report, its Return on Equity (ROE) was -215.88, with a year-on-year change of -106.38.

What is the Return on Assets (ROA) of Lexaria Bioscience Corp?

According to Lexaria Bioscience Corp's FY2025 earnings report, its Return on Assets (ROA) was -182.65, with a year-on-year change of -87.91.

What is the operating profit of Lexaria Bioscience Corp?

According to Lexaria Bioscience Corp's FY2025 earnings report, its operating profit was -11.88M, with a year-on-year change of -106.51.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.